相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
Rita G. Ladstein et al.
BMC CANCER (2010)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
Improved Survival for Stage IV Melanoma From an Unknown Primary Site
Chris C. Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
Dusan Bogunovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma
Anne Brecht Francken et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Systemic therapy for metastatic malignant melanoma - from deeply disappointing to bright future?
Paul Lorigan et al.
EXPERIMENTAL DERMATOLOGY (2008)
Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma
Chris C. Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy
Kimberly M. Dalal et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Molecularly targeted therapy for melanoma - Current reality and future options
Juergen C. Becker et al.
CANCER (2006)
Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma
PA Gimotty et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Thin primary cutaneous malignant melanoma: A prognostic tree for 10-year metastasis is more accurate than American joint committee on cancer staging
PA Gimotty et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases
DL Smith et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Apoptosis and melanoma chemoresistance
MS Soengas et al.
ONCOGENE (2003)
Correlation between MIB-1 and other proliferation markers -: Clinical implications of the MIB-1 cutoff value
F Spyratos et al.
CANCER (2002)
Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases
H Petrowsky et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2001)
Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens
NR Mucci et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
